In 2023, the American Society of Anesthesiologists issued more specific recommendations: discontinuation 1 day prior to surgery for patients using daily formulations, and 1 week prior for weekly formulations
However, always consult your doctor before combining treatments, especially if taking other medications or supplements
Glucagon-Receptor Activity Considerations Unlike traditional GLP-1focused compounds, Retatrutide also interacts with glucagon receptors, which are researched for their potential role in: Increased energy expenditure Fat oxidation Metabolic-rate modulation This broader receptor activity may contribute to differences in appetite regulation, energy balance, and metabolic response compared to earlier incretin-based research peptides
the first week brings appetite suppression, not weight loss
It should be noted that the United States Department of Justice filed a lawsuit against Novo Nordisk nearly 15 years ago for fraudulently and aggressively marketing their diabetes drugs